Skip over navigation
Banner
Directory
Directory Search
Jobs
Job Search Post a Job
Patient
Patient Resources Drug Development
History
Genealogy
Toons & Teasers
Industry
 Directory
 Toons & Teasers
Quick Links
 Directory
 Job Search
 Toons & Teasers
 Advertising
 
Events
 

EquipNet Auction: Sell your surplus on our global marketplace: No cost to list equipment!

Check Out Our Newest Cartoon: "Milestones in Diabetes"

North American Biotech Roadshow Featuring Grad Students, Post-Docs & Start-Up “Do’s & Don’ts”


Washington Life Science Industry Directory

EquipNet Auction: Sell your surplus on our global marketplace: No cost to list equipment!

Banner Advertising

Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and delayed by COVID-19, to be launched in 2022 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved directory upon the launch of the new site. We apologize for the inconvenience.

Immune Design Corp.


Immune Design Corp.
1616 Eastlake Ave. E., Suite 310
Seattle, WA 98102
Immune Design Corp.
 
Phone: (206) 682-0645
Fax: (206) 682-0648
Year Established:  2008
Employees: 30
Ticker: IMDZ
Exchange: NASDAQ
Main Contact: Stephen R. Brady, Executive VP, Strategy & Finance
 
Other Contacts:  Jan Henrik ter Meulen, M.D., Dr. habil., DTM&H, CSO
Frank J. Hsu, M.D., VP, Head of Oncology
Sergey Yurasov, M.D., Ph.D., Senior VP, Clinical Development & CMO
Carlos Paya, M.D., Ph.D., President & CEO
Wayne Gombotz, Ph.D., Chief Development Officer
Christopher Whitmore, CPA, VP, Finance & Administration
 
Company Description

Immune Design (formerly Vaccsys) is a clinical-stage immunotherapy company employing leading-edge technologies that target dendritic cells in vivo to generate and expand strong cytotoxic T cells (CTLs) for the treatment of cancer and other chronic diseases. The company has a multi-faceted set of clinical programs on going that are the product of its two synergistic discovery platforms: DCVexTM, a novel lentiviral vector platform engineered to deliver antigen-encoding nucleic acids directly to dendritic cells in vivo; and GLAASTM, a TLR4-agonist platform that activates dendritic cells by up-regulating key molecules for efficient antigen presentation and produces Th1 cytokines to enhance the immune response. Immune Design has offices in Seattle, Washington and South San Francisco, California.

The company’s scientific founders have each made significant contributions to the field of immunotherapy and the treatment of chronic disease: Dr. Larry Corey (President and Director of the Fred Hutchinson Cancer Research Center and Professor of Medicine and Laboratory Medicine at the University of Washington), Dr. Steven Reed (Past Co-founder and CSO of Corixa and Founder, President, and CSO of the Infectious Disease Research Institute) and Dr. David Baltimore (Past President of Caltech, Rockefeller University, and the Whitehead Institute and the Co-Recipient of the 1975 Nobel Prize in Physiology or Medicine). Immune Design’s Scientific Advisory Board is comprised of senior investigators Drs. Larry Corey, Rafi Ahmed, David Baltimore, Philip Greenberg, Carl June, Steven Reed, Inder Verma, and Ralph Steinman (late).



Main Industry Directory

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 1997 - 2022 Info.Resource, Inc. All rights reserved.
Privacy Policy . Cookie Policy . Terms of Use . About . Advertising

WashingtonLifeScience.com is owned and published by Info.Resource, Inc.